Doctor Ana Beatriz Garcia
CHULN and Faculty of medicine of the University of Lisbon, Lisbon (Portugal)
Member of:
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
Highlighting the importance of risk stratification and management in infective endocarditis
Event: Heart Failure 2024
Topic: Epidemiology, Prognosis, Outcome
Session: ePosters in valvular and pulmonary 3
MYBPC3 genotypes associated with familial hypertrophic cardiomyopathy
Event: Heart Failure 2024
Topic: Pathophysiology
Session: Chronic heart failure - pathophysiology and mechanisms 6
Catch them little to go for super response
Event: Heart Failure 2023
Topic: Cardiac Resynchronisation Therapy (CRT)
Session: Device therapy 2
Survival analysis in a population with cardiac amyloidosis
Event: Heart Failure 2023
Topic: Clinical
Session: Myocardial disease - clinical 3
Transthyretin-directed antisense oligonucleotide therapy effects on ATTRv myocardiopathy
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Chronic heart failure - pharmacotherapy 2
Signalling amyloidosis diagnosis with red flags
Event: Heart Failure 2022
Topic: Diagnostic Methods
Session: Heart Failure ePosters - focus on Chronic Heart Failure 6
The need for diuretic therapy in spite of heart failure with reduced ejection fraction foundational therapy: a new marker of adverse prognosis?
Event: Heart Failure 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Heart Failure ePosters - focus on Acute Heart Failure
Epicardial mapping as first intention approach for structural ventricular tachycardia ablation
Event: EHRA 2022
Topic: Catheter Ablation of Arrhythmias
Session: ePosters Day 2
